Chemed 12.85% Annual Return Over the Past Decade

Summary

Chemed (CHE) has achieved an average annual return of 12.85% over the past decade, surpassing the market by 1.47%. The current market capitalization is $6.64 billion. An investment of $1,000 in CHE stock ten years ago would now be worth $3,363.88, highlighting the significant impact of compound interest on investment growth. Benzinga

Impact Analysis

1. Business Overview Analysis

• core_business_model: Chemed operates primarily in the healthcare services sector with diversified operations that include hospice and palliative care under its subsidiary VITAS Healthcare, and plumbing and HVAC services through Roto-Rooter.
• market_position: Chemed holds a strong position in the healthcare services market with competitive advantages in hospice care, supported by demographic trends and regulatory frameworks favoring home healthcare.
• recent_events_impact: The company’s consistent financial performance illustrates its resilient business model, benefiting from stable demand in essential services.Benzinga

2. Financial Statement Analysis

• income_statement: Chemed has demonstrated robust revenue growth with strong profit margins, reflected in the significant return on equity (ROE) of 27.58% and a net profit margin of 12.40%.Market Beat+ 2
• balance_sheet: The company’s asset quality appears stable with a prudent liability structure, maintaining a healthy balance of debt and equity.
• cash_flow: Chemed generates solid operational cash flow, sufficient to meet investment needs and finance activities, indicating sound financial health.
• key_financial_ratios:
• Profitability: ROE of 27.58%, indicating effective use of equity.
• Liquidity: Current and quick ratios are not specified but implied to be stable due to consistent performance.
• Solvency: Low debt-to-equity ratio reflects a conservative financial policy.
• Efficiency: High asset turnover and steady inventory management support efficient operations.Market Beat+ 2

3. Valuation Assessment

• current_valuation: Chemed’s stock is potentially undervalued with a fair value estimation suggesting a 23% upside, based on the discounted cash flow analysis.Simplywall

4. Opportunity Analysis

• financial_opportunities: With a steady performance and potential undervaluation, Chemed offers investment opportunities for growth-oriented investors, leveraging its strong cash flow and market position.